Avandia
May 14, 2008
Swiss Scientists Confirm Avandia's Link to Osteoporosis
Swiss researchers recently concluded that Avandia, a type 2 diabetes drug, nearly doubles the chances of osteoporosis and bone fracture among patients who take the drug and is increased for patients taking the drug for more than a year. The results of the study come on heels of controversy surrounding the drug’s link to increased heart disease and various studies warning of potential risks related to bone degradation.
Continue reading "Swiss Scientists Confirm Avandia's Link to Osteoporosis" »
Posted by Alan Haburchak at 05:54 PM | Permalink
August 10, 2007
GlaxoSmithKline: Avandia Unlikely to Recover
The U.S. Food and Drug Administration recently voted to keep Avandia on the market. Avandia is a drug manufactured by GlaxoSmithKline and it is used to treat type 2 diabetes. However, though the news would seem positive for GlaxoSmithKline, the FDA's treatment of the situation has called into question the FDA's ability to manage situations such as these and the review likely will damage Avandia sales.
Continue reading "GlaxoSmithKline: Avandia Unlikely to Recover" »
Posted by Patricia Bowling at 11:03 PM | Permalink
August 09, 2007
Warning Label Urged for Avandia
A U.S. Food and Drug Administration panel has concluded that diabetes patients taking the drug Avandia to treat their condition have a greater risk of heart attack than those taking other drugs to treat their conditions. While the panel did not advise removing the drug from the market, they did say that Avandia needs a stricter warning on its label.
Warning Label Urged for Avandia
Continue reading "Warning Label Urged for Avandia" »
Posted by Patricia Bowling at 10:16 PM | Permalink
Reports of Avandia-Related Heart Attacks Jumps
The side effects noted by patients taking diabetes drug Avandia tripled in the months after a study linked the drug to increased rates of heart attacks. A report from the U.S. Food and Drug Administration says: "In the 35 days after May 21, when the New England Journal of Medicine published the analysis on the Internet, reports of heart attacks, deaths and hospitalizations leaped... Only five heart attacks were reported in the 35 days before the study, compared with 90 in the same period afterward. Heart-related hospitalizations went from 11 to 126. The reports involve rosiglitazone, sold as Avandia and Avandamet."
Reports of Avandia-Related Heart Attacks Jump, Highlight Flawed FDA Monitoring
Continue reading "Reports of Avandia-Related Heart Attacks Jumps" »
Posted by Patricia Bowling at 08:52 PM | Permalink
August 08, 2007
Class Action Filed Against Avandia
A class action lawsuit has been filed against GlaxoSmithKline, saying that the drug company did not do enough to alert those taking the drug of the drug's risk. The lawsuit was filed at the Court of Queen's Bench in Regina on the behalf of a 75-year-old woman who died in May after having taken Avandia.
Class Action Suit Launched Over Avandia
Continue reading "Class Action Filed Against Avandia" »
Posted by Patricia Bowling at 09:07 PM | Permalink
